Free Trial

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Short Interest Up 7.5% in October

Acadia Healthcare logo with Medical background

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) was the target of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 5,990,000 shares, a growth of 7.5% from the October 15th total of 5,570,000 shares. Based on an average daily volume of 1,480,000 shares, the short-interest ratio is currently 4.0 days.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on ACHC shares. Royal Bank of Canada restated an "outperform" rating and set a $94.00 price target on shares of Acadia Healthcare in a report on Friday, September 20th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a "hold" rating in a report on Friday, August 2nd. StockNews.com upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Thursday. Barclays reduced their target price on Acadia Healthcare from $83.00 to $76.00 and set an "overweight" rating for the company in a research note on Monday, September 30th. Finally, KeyCorp started coverage on Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating on the stock. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and a consensus price target of $86.67.

Get Our Latest Analysis on ACHC

Acadia Healthcare Stock Down 3.9 %

Shares of ACHC stock traded down $1.54 during trading hours on Friday, reaching $37.82. The company had a trading volume of 1,846,000 shares, compared to its average volume of 1,941,511. The business has a fifty day simple moving average of $58.05 and a 200-day simple moving average of $65.55. Acadia Healthcare has a 12 month low of $37.78 and a 12 month high of $87.77. The company has a market cap of $3.51 billion, a price-to-earnings ratio of 12.40, a price-to-earnings-growth ratio of 1.68 and a beta of 1.33. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. During the same period last year, the firm earned $0.91 earnings per share. The firm's revenue was up 8.7% on a year-over-year basis. On average, research analysts expect that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several large investors have recently made changes to their positions in the business. Blue Trust Inc. lifted its position in shares of Acadia Healthcare by 86.1% during the second quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $36,000 after acquiring an additional 248 shares in the last quarter. GAMMA Investing LLC grew its position in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after acquiring an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in Acadia Healthcare in the 2nd quarter worth $59,000. Covestor Ltd lifted its stake in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after acquiring an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale bought a new stake in Acadia Healthcare in the third quarter valued at approximately $86,000.

About Acadia Healthcare

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

See Also

Should you invest $1,000 in Acadia Healthcare right now?

Before you consider Acadia Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.

While Acadia Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines